Purpose
Oxygen-ozone therapy (02-03 therapy) is one of the mini-invasive treatments for lumbar disc disease involving percutaneous injection which exploits the chemical properties of medical ozone, an unstable highly oxidising gas mixture. The aims of this study were to: -assess patient outcome six months after O2-03 therapy;
-compare the therapeutic outcome of ozone infiltration alone with injection of an O2-03 mixture containing a corticosteroid and an anaesthetic.
Material and Methods
From January 1999 to March 2001 600 patients aged between 20 and 80 years were treated by a single session of O2-03 therapy.
Patients presented clinical signs of lumbar nerve root irritation with CT and/or MR findings of contained disc herniation without or without inter-somatic disc degeneration. 300 patients (group A) were injected with 4 ml of an O2-03 mixture at a concentration of 27 _g/ml into the disc and 8 ml into the periganglion.
In addition to this procedure, 300 patients (group B) also received a periganglionic injection of a corticosteroid (lml di Depomedrol40 mg) and anaesthetic (2 ml Marcain at 0.50%).
Treatment outcome was assessed six months after treatment using a modified MacNab method.
Results
Treatment was successful in 74.3% of all patients: 70.3 % in group A and 78.3 % in group B. Treatment failure was 25.7%: 29.7% in group A and 21.7% in group B.
We discuss the criteria for patient selection, the success and failure rates of the treatment in relation to disease type and patient outcome.
Complications included two episodes of reduced sensitivity in the lower limb ipsilateral to treatment both of which resolved spontaneously within two hours.
Conclusions
The results obtained by O2-03 therapy were comparable to those of other mini-invasive treatments like Onik's nucleodiscectomy or enzymatic chemonucleolysis. Treatment proved more effective when the O2-03 mixture was combined with a corticosteroid, in agreement with literature findings on the intradiscal and periganglion infiltration of corticosteroids.
Our success rate following O2-03 therapy was satisfactory. 02-03 therapy is a treatment option in between conservative management and surgery and should be entertained when conservative treatment of symptomatic disc disease fails. 
